TY - JOUR
KW - pharmacoepidemiology
KW - Sodium-glucose cotransporter-2 inhibitors
KW - sudden cardiac arrest
AU - T. Eroglu
AU - R. Coronel
AU - C. Zuurbier
AU - M. Blom
AU - A. de Boer
AU - P. Souverein
AD - Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Amsterdam UMC, Academic Medical Center, University of Amsterdam, Department of Experimental and Clinical Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands.
Department of Anaesthesiology, Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), Amsterdam UMC, Location Academic Medical Centre (AMC), Amsterdam, University of Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.
Amsterdam UMC location Vrije Universiteit Amsterdam, General Practice, Boelelaan 1117, Amsterdam, The Netherlands.
Amsterdam Public Health Research institute, Health Behaviors & Chronic Diseases, Amsterdam, The Netherlands.
AN - 35894858
BT - Eur Heart J Cardiovasc Pharmacother
DO - 10.1093/ehjcvp/pvac043
DP - NLM
ET - 2022/07/28
LA - eng
N1 - 2055-6845
Eroglu, Talip E
Orcid: 0000-0002-4381-0068
Coronel, Ruben
Zuurbier, Coert J
Blom, Marieke
de Boer, Anthonius
Souverein, Patrick C
Journal Article
England
Eur Heart J Cardiovasc Pharmacother. 2022 Jul 27:pvac043. doi: 10.1093/ehjcvp/pvac043.
PY - 2022
T2 - Eur Heart J Cardiovasc Pharmacother
TI - Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
ER -